Protein Restriction Promotes Longevity via FGF21
research · Initial discovery linking FGF21 to protein restriction and lifespan extension in mice (2011)
Reducing dietary protein or specific amino acids activates fibroblast growth factor 21 (FGF21), a liver-derived hormone that mimics many benefits of caloric restriction. FGF21 enhances metabolic health, stress resistance, and lifespan, primarily through signaling in the brain and adipose tissue. This pathway explains why low-protein diets can extend healthspan without the need for total calorie reduction.
Core Concepts
The Problem
Caloric restriction extends lifespan but is difficult to sustain. Identifying specific dietary modifiers that trigger similar pathways is key.
The Claim
Protein restriction, via FGF21, activates longevity pathways independent of calorie intake, offering a more practical anti-aging strategy.
Key Evidence
- •Mouse studies show protein restriction extends lifespan, and FGF21 knockout abolishes this effect.
- •Human epidemiological data link lower protein intake to reduced age-related disease.
- •FGF21 levels rise during fasting and low-protein conditions, correlating with health improvements.
Practical Implication
Targeting FGF21 or practicing intermittent protein restriction could mimic anti-aging effects without chronic deprivation.
Nuance & Limits
The benefits may be more pronounced in mid-life and for specific cancers, while adequate protein remains essential for muscle maintenance in older adults.
Source Material
Citation Density
high
Gaps
- ⚠ Optimal human protein restriction protocols undefined
- ⚠ Interaction with exercise-induced muscle synthesis needs clarification
Who's Talking About This
1 episode reference this idea.
Discuss Further
Open this concept in an AI assistant for deeper discussion, critique, or exploration.